Alpha Teknova (NASDAQ:TKNO) Issues Quarterly Earnings Results

Alpha Teknova (NASDAQ:TKNO) announced its quarterly earnings data on Wednesday. The company reported ($0.06) EPS for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.01, FiscalAI reports. Alpha Teknova had a negative net margin of 38.37% and a negative return on equity of 24.94%. The company had revenue of $12.70 million for the quarter, compared to the consensus estimate of $11.71 million.

Alpha Teknova Stock Performance

TKNO traded up $0.03 during trading on Wednesday, hitting $7.37. 371,985 shares of the stock were exchanged, compared to its average volume of 259,286. The company has a quick ratio of 3.48, a current ratio of 4.49 and a debt-to-equity ratio of 0.21. Alpha Teknova has a 1-year low of $1.91 and a 1-year high of $9.48. The stock has a fifty day moving average price of $7.71 and a two-hundred day moving average price of $4.92. The firm has a market capitalization of $395.77 million, a P/E ratio of -23.77 and a beta of 0.96.

Analysts Set New Price Targets

A number of research firms have recently commented on TKNO. BTIG Research upgraded Alpha Teknova from a “neutral” rating to a “buy” rating and set a $8.00 price objective on the stock in a report on Tuesday, August 11th. Jefferies Financial Group began coverage on shares of Alpha Teknova in a research note on Thursday, September 17th. They issued a “buy” rating and a $9.00 price target on the stock. Weiss Ratings cut shares of Alpha Teknova from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday, August 11th. Roth Capital began coverage on shares of Alpha Teknova in a research report on Wednesday, August 5th. They set a “buy” rating and a $7.00 price objective for the company. Finally, Zacks Research upgraded shares of Alpha Teknova to a “hold” rating in a report on Thursday, August 6th. Four analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $8.75.

Alpha Teknova Company Profile

Alpha Teknova, Inc is a life sciences company that develops and manufactures critical reagents and other products used in biomedical research, biopharmaceutical development and advanced therapies. The company provides laboratory and production materials designed to support applications including cell and gene therapy, molecular diagnostics, next-generation sequencing, vaccine development and pharmaceutical manufacturing.

Its offerings include research-use-only and current Good Manufacturing Practice (cGMP) reagents, buffers, media and other custom-formulated solutions.